KIM D BLICKENSTAFF
CIK 1238913 · Executive Chairman · last filed 2026-05-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.21M
Companies
7
Total Filings
84
Lifetime Open-Market Net
-$158.96M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NUVB | Director | — | $6.46 | — | $0 | 1 | 2026-05-26 |
| Nuvation Bio Inc. (NUVB.WS) Delisted | Director | 172,189 | $0.01 | $878 | $500.1K | 8 | 2025-05-23 |
| TNDM | Director | 213,038 | $18.64 | $3.97M | -$146.63M | 46 | 2024-11-22 |
| MEDIVATION, INC. (MDVN) Delisted | Director | 43,242 | — | — | -$12.84M | 18 | 2016-09-26 |
| SENORX INC (SENO) Delisted | Director | 0 | — | — | $0 | 5 | 2010-07-07 |
| BIOSITE INC (BSTE) Delisted | Chairman & CEO | 0 | — | — | $0 | 2 | 2007-07-02 |
| DXCM | Director | 16,416 | $75.31 | $1.24M | $0 | 1 | 2007-05-25 |
Recent Filings · Page 3 of 9
84 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-08-10 | TNDM | Sell (S) | −82,800 | -$8.92M | EDGAR |
| 2021-06-15 | TNDM | Gift (G) | −12,000 | -$1.10M | EDGAR |
| 2021-06-10 | TNDM | Sell (S) | −38,000 | -$3.35M | EDGAR |
| 2021-06-01 | TNDM | Exer (M) | +1,892 | $0 | EDGAR |
| 2021-05-20 | TNDM | Grant (A) | — | $0 | EDGAR |
| 2021-03-17 | TNDM | Sell (S) | −200,000 | -$17.45M | EDGAR |
| 2021-02-12 | Nuvation Bio Inc. (NUVB.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-12-17 | TNDM | Sell (S) | −108,198 | -$9.52M | EDGAR |
| 2020-12-15 | TNDM | Sell (S) | −9,150 | -$851.0K | EDGAR |
| 2020-12-10 | TNDM | Mixed | −54,850 | -$5.09M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.